BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7854380)

  • 1. The cost effectiveness of preoperative autologous blood donations.
    Etchason J; Petz L; Keeler E; Calhoun L; Kleinman S; Snider C; Fink A; Brook R
    N Engl J Med; 1995 Mar; 332(11):719-24. PubMed ID: 7854380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a decision model for long-term outcomes.
    Vitale MG; Roye BD; Ruchelsman DE; Roye DP
    Spine J; 2007; 7(3):292-300. PubMed ID: 17482112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness.
    Dietrich W; Thuermel K; Heyde S; Busley R; Berger K
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):589-96. PubMed ID: 16202891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis.
    Healy JC; Frankforter SA; Graves BK; Reddy RL; Beck JR
    Arch Pathol Lab Med; 1994 Apr; 118(4):465-70. PubMed ID: 8166599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous transfusion and other approaches to reduce allogeneic blood exposure.
    Vamvakas EC; Pineda AA
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):533-47. PubMed ID: 11102275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
    Green WS; Toy P; Bozic KJ
    J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery.
    Blumberg N; Kirkley SA; Heal JM
    Am J Surg; 1996 Mar; 171(3):324-30. PubMed ID: 8615466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autologous blood donation versus homologous blood transfusion--an analysis of cost effectiveness].
    Dietrich GV
    Zentralbl Chir; 1996; 121(10):841-6. PubMed ID: 9019932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood salvage produces higher total blood product costs in single-level lumbar spine surgery.
    Canan CE; Myers JA; Owens RK; Crawford CH; Djurasovic M; Burke LO; Bratcher KR; McCarthy KJ; Carreon LY
    Spine (Phila Pa 1976); 2013 Apr; 38(8):703-8. PubMed ID: 23044618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative autologous transfusion during elective infrarenal aortic reconstruction: a decision analysis model.
    Huber TS; McGorray SP; Carlton LC; Irwin PB; Flug RR; Flynn TC; Seeger JM
    J Vasc Surg; 1997 Jun; 25(6):984-93; discussion 993-4. PubMed ID: 9201158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical aspects of preoperative autologous transfusion.
    Yomtovian R
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S28-35. PubMed ID: 9124227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group.
    Tretiak R; Laupacis A; Rivière M; McKerracher K; Souêtre E
    CMAJ; 1996 May; 154(10):1501-8. PubMed ID: 8625000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures.
    Goodnough LM; Grishaber JE; Birkmeyer JD; Monk TG; Catalona WJ
    Urology; 1994 Aug; 44(2):226-31. PubMed ID: 8048198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery.
    Dupuis JY; Bart B; Bryson G; Robblee J
    CMAJ; 1999 Apr; 160(7):997-1002. PubMed ID: 10207338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridgeport Hospital autologous blood donation experience from 1992 to 1996.
    Bernstein LH; Coles M; Viner N
    Yale J Biol Med; 1995; 68(5-6):207-13. PubMed ID: 8903045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting.
    Birkmeyer JD; AuBuchon JP; Littenberg B; O'Connor GT; Nease RF; Nugent WC; Goodnough LT
    Ann Thorac Surg; 1994 Jan; 57(1):161-8; discussion 168-9. PubMed ID: 8279884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for predicting transfusion requirements in head and neck surgery.
    Weber RS
    Laryngoscope; 1995 Aug; 105(8 Pt 2 Suppl 73):1-17. PubMed ID: 7630307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous versus allogeneic transfusion: patients' perceptions and experiences.
    Graham ID; Fergusson D; Dokainish H; Biggs J; McAuley L; Laupacis A
    CMAJ; 1999 Apr; 160(7):989-95. PubMed ID: 10207337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of epoetin and autologous blood donationin reducing allogeneic blood transfusions incoronary artery bypass graft surgery.
    Marchetti M; Barosi G
    Transfusion; 2000 Jun; 40(6):673-81. PubMed ID: 10864987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative hemodilution is more cost-effective than preoperative autologous donation for patients undergoing procedures associated with a low risk for transfusion.
    Rosenblatt MA; Cantos EM; Mohandas K
    J Clin Anesth; 1997 Feb; 9(1):26-9. PubMed ID: 9051542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.